Search

Scott A. Browne

Examiner (ID: 11727, Phone: (571)270-0151 , Office: P/3617 )

Most Active Art Unit
3617
Art Unit(s)
3666, 4128, 3615, 3617
Total Applications
544
Issued Applications
383
Pending Applications
20
Abandoned Applications
143

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4824914 [patent_doc_number] => 20080124319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Methods for treating inflammation by disrupting MCH-mediated signaling' [patent_app_type] => utility [patent_app_number] => 11/804013 [patent_app_country] => US [patent_app_date] => 2007-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6997 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124319.pdf [firstpage_image] =>[orig_patent_app_number] => 11804013 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/804013
Methods for treating inflammation by disrupting MCH-mediated signaling May 15, 2007 Abandoned
Array ( [id] => 4779356 [patent_doc_number] => 20080287354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Prosaposin as a neurotrophic factor' [patent_app_type] => utility [patent_app_number] => 11/787486 [patent_app_country] => US [patent_app_date] => 2007-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6331 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287354.pdf [firstpage_image] =>[orig_patent_app_number] => 11787486 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/787486
Prosaposin as a neurotrophic factor Apr 15, 2007 Abandoned
Array ( [id] => 4915232 [patent_doc_number] => 20080095832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-24 [patent_title] => 'Prosaposin as a neurotrophic factor' [patent_app_type] => utility [patent_app_number] => 11/787565 [patent_app_country] => US [patent_app_date] => 2007-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6333 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20080095832.pdf [firstpage_image] =>[orig_patent_app_number] => 11787565 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/787565
Prosaposin as a neurotrophic factor Apr 15, 2007 Abandoned
Array ( [id] => 5187982 [patent_doc_number] => 20070166290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Lineage Restricted Glial Precursors from the Central Nervous System' [patent_app_type] => utility [patent_app_number] => 11/694221 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11205 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20070166290.pdf [firstpage_image] =>[orig_patent_app_number] => 11694221 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/694221
Lineage restricted glial precursors from the central nervous system Mar 29, 2007 Issued
Array ( [id] => 8642631 [patent_doc_number] => 08367615 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-05 [patent_title] => 'Stimulation of neuron regeneration by secretory leukocyte protease inhibitor' [patent_app_type] => utility [patent_app_number] => 12/225639 [patent_app_country] => US [patent_app_date] => 2007-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14219 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12225639 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/225639
Stimulation of neuron regeneration by secretory leukocyte protease inhibitor Mar 29, 2007 Issued
Array ( [id] => 6615741 [patent_doc_number] => 20100310570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'MAPC TREATMENT OF BRAIN INJURIES AND DISEASES' [patent_app_type] => utility [patent_app_number] => 12/161830 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19376 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310570.pdf [firstpage_image] =>[orig_patent_app_number] => 12161830 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/161830
MAPC treatment of brain injuries and diseases Jan 22, 2007 Issued
Array ( [id] => 6615741 [patent_doc_number] => 20100310570 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'MAPC TREATMENT OF BRAIN INJURIES AND DISEASES' [patent_app_type] => utility [patent_app_number] => 12/161830 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19376 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310570.pdf [firstpage_image] =>[orig_patent_app_number] => 12161830 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/161830
MAPC treatment of brain injuries and diseases Jan 22, 2007 Issued
Array ( [id] => 4982821 [patent_doc_number] => 20070087379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'YS68 gene involved in primitive hematopoiesis' [patent_app_type] => utility [patent_app_number] => 11/643069 [patent_app_country] => US [patent_app_date] => 2006-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16687 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20070087379.pdf [firstpage_image] =>[orig_patent_app_number] => 11643069 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/643069
YS68 gene involved in primitive hematopoiesis Dec 19, 2006 Issued
Array ( [id] => 5113747 [patent_doc_number] => 20070197663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Methods of treating memory and cognitive impairments in humans following stroke and traumatic brain injury' [patent_app_type] => utility [patent_app_number] => 11/636703 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 59955 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197663.pdf [firstpage_image] =>[orig_patent_app_number] => 11636703 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/636703
Methods of treating memory and cognitive impairments in humans following stroke and traumatic brain injury Dec 7, 2006 Abandoned
Array ( [id] => 8981843 [patent_doc_number] => 08512958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-20 [patent_title] => 'Methods of identifying agents that modulate mitochondrial function' [patent_app_type] => utility [patent_app_number] => 11/636110 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 20 [patent_no_of_words] => 19744 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11636110 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/636110
Methods of identifying agents that modulate mitochondrial function Dec 6, 2006 Issued
Array ( [id] => 4676851 [patent_doc_number] => 20080214482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Retromer-based assays and methods for treating alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 11/599896 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9668 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214482.pdf [firstpage_image] =>[orig_patent_app_number] => 11599896 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/599896
Retromer-based assays and methods for treating alzheimer's disease Nov 13, 2006 Abandoned
Array ( [id] => 5125900 [patent_doc_number] => 20070238171 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations' [patent_app_type] => utility [patent_app_number] => 11/590686 [patent_app_country] => US [patent_app_date] => 2006-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13120 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238171.pdf [firstpage_image] =>[orig_patent_app_number] => 11590686 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/590686
Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations Oct 30, 2006 Abandoned
Array ( [id] => 4824798 [patent_doc_number] => 20080124276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Synthetic cornea from retinal stem cells' [patent_app_type] => utility [patent_app_number] => 11/584412 [patent_app_country] => US [patent_app_date] => 2006-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 49092 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124276.pdf [firstpage_image] =>[orig_patent_app_number] => 11584412 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/584412
Synthetic cornea from retinal stem cells Oct 18, 2006 Abandoned
Array ( [id] => 5034168 [patent_doc_number] => 20070098707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Methods and Compositions for Inhibiting C-MET Dimerization and Activation' [patent_app_type] => utility [patent_app_number] => 11/537751 [patent_app_country] => US [patent_app_date] => 2006-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 24058 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098707.pdf [firstpage_image] =>[orig_patent_app_number] => 11537751 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/537751
Methods and Compositions for Inhibiting C-MET Dimerization and Activation Oct 1, 2006 Abandoned
Array ( [id] => 7691498 [patent_doc_number] => 20070232535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'GFRalpha3 and its uses' [patent_app_type] => utility [patent_app_number] => 11/529680 [patent_app_country] => US [patent_app_date] => 2006-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 33412 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232535.pdf [firstpage_image] =>[orig_patent_app_number] => 11529680 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/529680
GFRα3 polypeptides Sep 26, 2006 Issued
Array ( [id] => 5108979 [patent_doc_number] => 20070067857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Therapeutic agent for NGF' [patent_app_type] => utility [patent_app_number] => 11/519773 [patent_app_country] => US [patent_app_date] => 2006-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 11594 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20070067857.pdf [firstpage_image] =>[orig_patent_app_number] => 11519773 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/519773
Therapeutic agent for NGF Sep 12, 2006 Abandoned
Array ( [id] => 5108978 [patent_doc_number] => 20070067856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => ' Therapeutic agent for NGF' [patent_app_type] => utility [patent_app_number] => 11/519772 [patent_app_country] => US [patent_app_date] => 2006-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 11563 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0067/20070067856.pdf [firstpage_image] =>[orig_patent_app_number] => 11519772 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/519772
Therapeutic agent for NGF Sep 12, 2006 Abandoned
Array ( [id] => 4771858 [patent_doc_number] => 20080057516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Novel receptor for GDNF family ligands' [patent_app_type] => utility [patent_app_number] => 11/512408 [patent_app_country] => US [patent_app_date] => 2006-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13045 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20080057516.pdf [firstpage_image] =>[orig_patent_app_number] => 11512408 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/512408
Receptor for GDNF family ligands Aug 29, 2006 Issued
Array ( [id] => 5532947 [patent_doc_number] => 20090232735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'USE OF FRUCTOSE-BASED THERAPIES FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/064491 [patent_app_country] => US [patent_app_date] => 2006-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 26686 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232735.pdf [firstpage_image] =>[orig_patent_app_number] => 12064491 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/064491
USE OF FRUCTOSE-BASED THERAPIES FOR THE TREATMENT OF CANCER Aug 23, 2006 Abandoned
Array ( [id] => 5688925 [patent_doc_number] => 20060287240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Method of stimulating prosaposin receptor activity' [patent_app_type] => utility [patent_app_number] => 11/508033 [patent_app_country] => US [patent_app_date] => 2006-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3457 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287240.pdf [firstpage_image] =>[orig_patent_app_number] => 11508033 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/508033
Method of stimulating prosaposin receptor activity Aug 20, 2006 Abandoned
Menu